or
forgot password
  • cancer clinical trials in iowa city, IA

  • Intraperitoneal Paclitaxel, Doxorubicin, and Cisplatin in Treating Patients With Endometrial Cancer
    Holden Comprehensive Cancer Center at University of Iowa
    Iowa City, Iowa 52242-1002
    Endometrial Cancer, Ovarian Cancer
    Phase II Study of Adenovirus/PSA Vaccine in Men With Hormone - Refractory Prostate Cancer
    Holden Comprehensive Cancer Center
    Iowa City, Iowa 52242-1009
    Hormone Refractory Prostate Cancer
    Dose Escalation Phase I/II Study of Lovastatin With High-Dose Cytarabine for Refractory or Relapsed AML
    Holden Comprehensive Cancer Center
    Iowa City, Iowa 52242-1009
    Acute Myeloid Leukemia
    Phase II Study of Adenovirus/PSA Vaccine in Men With Recurrent Prostate Cancer After Local Therapy APP21
    Holden Comprehensive Cancer Center
    Iowa City, Iowa 52242-1009
    Recurrent Prostate Cancer
    Ultrasound Targeting for the Lumpectomy Cavity
    The University of Iowa Hospitals & Clinics
    Iowa City, Iowa 52242
    Mastectomy, Segmental
    A Phase II Study of Interaction of Lovastatin and Paclitaxel For Patients With Refractory or Relapsed Ovarian Cancer
    Holden Comprehensive Cancer Center
    Iowa City, Iowa 52242-1009
    Ovarian Cancer
    Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
    University of Iowa Hospitals and Clinics
    Iowa City, Iowa 52242
    Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma, Recurrent Metastatic Squamous Neck Cancer With Occult Primary, Recurrent Salivary Gland Cancer, Recurrent Squamous Cell Carcinoma of the Hypopharynx, Recurrent Squamous Cell Carcinoma of the Larynx, Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity, Recurrent Squamous Cell Carcinoma of the Nasopharynx, Recurrent Squamous Cell Carcinoma of the Oropharynx, Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Recurrent Verrucous Carcinoma of the Larynx, Recurrent Verrucous Carcinoma of the Oral Cavity, Salivary Gland Squamous Cell Carcinoma, Stage IV Salivary Gland Cancer, Stage IV Squamous Cell Carcinoma of the Hypopharynx, Stage IV Squamous Cell Carcinoma of the Larynx, Stage IV Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage IV Squamous Cell Carcinoma of the Nasopharynx, Stage IV Squamous Cell Carcinoma of the Oropharynx, Stage IV Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Stage IV Verrucous Carcinoma of the Larynx, Stage IV Verrucous Carcinoma of the Oral Cavity, Tongue Cancer, Untreated Metastatic Squamous Neck Cancer With Occult Primary
    Tamoxifen Citrate or Letrozole With or Without Bevacizumab in Treating Women With Stage III or Stage IV Breast Cancer
    University of Iowa Hospitals and Clinics
    Iowa City, Iowa 52242
    Recurrent Breast Cancer, Stage IIIB Breast Cancer, Stage IV Breast Cancer
    Fludarabine and Rituximab With or Without Lenalidomide or Cyclophosphamide in Treating Patients With Symptomatic Chronic Lymphocytic Leukemia
    University of Iowa Hospitals and Clinics

    Trial Locations
    University of Iowa Hospitals and Clinics
    VA Medical Center - University of Iowa
    B-cell Chronic Lymphocytic Leukemia, Stage I Chronic Lymphocytic Leukemia, Stage II Chronic Lymphocytic Leukemia, Stage III Chronic Lymphocytic Leukemia, Stage IV Chronic Lymphocytic Leukemia
    Safety and Effectiveness of Granulocyte Transfusions in Resolving Infection in People With Neutropenia (The RING Study)
    University of Iowa Hospitals and Clinics
    Iowa City, Iowa 52242
    Neutropenia, Infection
    Defibrotide for Patients With Hepatic Veno-occlusive Disease: A Treatment IND Study
    University of Iowa Hospitals & Clinics
    Iowa City, Iowa 52242
    Hepatic Veno-Occlusive Disease
    Daunorubicin, Cytarabine, and Midostaurin in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia
    Holden Comprehensive Cancer Center at University of Iowa
    Iowa City, Iowa 52242-1002
    Leukemia
    Pentostatin, Alemtuzumab, and Rituximab in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
    Holden Comprehensive Cancer Center at University of Iowa
    Iowa City, Iowa 52242-1002
    Leukemia, Lymphoma
    A Phase 1 Safety Study of LY2127399 in Combination With Bortezomib in Patients With Relapsed or Refractory Multiple Myeloma
    University of Iowa Hospitals and Clinics
    Iowa City, Iowa 52242
    Relapsed or Refractory Multiple Myeloma
    Genetic Mutations and Environmental Exposure in Young Patients With Retinoblastoma and in Their Parents and Young Healthy Unrelated Volunteers
    Holden Comprehensive Cancer Center at University of Iowa
    Iowa City, Iowa 52242-1002
    Retinoblastoma
    Sunitinib as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Treated With Combination Chemotherapy
    University of Iowa Hospitals and Clinics

    Trial Locations
    University of Iowa Hospitals and Clinics
    VA Medical Center - University of Iowa
    Stage IIIB Non-small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer
    Efficacy of XL184 (Cabozantinib) in Advanced Medullary Thyroid Cancer
    University of Iowa
    Iowa City, Iowa 52242
    Thyroid Cancer
    Sodium Thiosulfate in Preventing Hearing Loss in Young Patients Receiving Cisplatin for Newly Diagnosed Germ Cell Tumor, Hepatoblastoma, Medulloblastoma, Neuroblastoma, Osteosarcoma, or Other Malignancy
    Holden Comprehensive Cancer Center at University of Iowa
    Iowa City, Iowa 52242-1002
    Brain and Central Nervous System Tumors, Childhood Germ Cell Tumor, Extragonadal Germ Cell Tumor, Liver Cancer, Neuroblastoma, Ototoxicity, Ovarian Cancer, Sarcoma
    Efficacy and Safety of Nilotinib Patients With Newly Diagnosed CML - CP (Chronic Myelogenous Leukemia - Chronic Phase)
    University of Iowa Hospitals and Clinics Dept.of U of Iowa Hosp&Clinics
    Iowa City, Iowa 52242
    Myelogenous Leukemia, Chronic
    D-dimer to Select Patients With First Unprovoked Venous Thromboembolism Who Can Have Anticoagulants Stopped at 3 Months
    University of Iowa Hospitals and Clinics
    Iowa City, Iowa 52242
    Deep Vein Thrombosis, Pulmonary Embolism
    F-18 Fluorothymidine PET Imaging for Early Evaluation of Response to Therapy in Head & Neck Cancer Patients
    University of Iowa Hospitals and Clinics
    Iowa City, Iowa 52242
    Mouth Neoplasms, Oropharyngeal Neoplasms, Laryngeal Neoplasms, Head and Neck Neoplasms
    Bevacizumab and Temsirolimus in Treating Patients With Recurrent or Persistent Endometrial Cancer
    University of Iowa Hospitals and Clinics
    Iowa City, Iowa 52242
    Recurrent Endometrial Carcinoma
    Laparoscopic-Assisted Resection or Open Resection in Treating Patients With Stage IIA, Stage IIIA, or Stage IIIB Rectal Cancer
    Holden Comprehensive Cancer Center at University of Iowa
    Iowa City, Iowa 52242-1002
    Colorectal Cancer
    Temsirolimus With or Without Megestrol and Tamoxifen in Treating Patients With Advanced, Persistent, or Recurrent Endometrial Cancer
    University of Iowa Hospitals and Clinics
    Iowa City, Iowa 52242
    Recurrent Endometrial Carcinoma, Stage III Endometrial Carcinoma, Stage IV Endometrial Carcinoma
    Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
    University of Iowa Hospitals and Clinics
    Iowa City, Iowa 52242
    Accelerated Phase Chronic Myelogenous Leukemia, Acute Myeloid Leukemia/Transient Myeloproliferative Disorder, Acute Undifferentiated Leukemia, Angioimmunoblastic T-cell Lymphoma, Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative, Blastic Phase Chronic Myelogenous Leukemia, Childhood Acute Lymphoblastic Leukemia in Remission, Childhood Acute Myeloid Leukemia in Remission, Childhood Burkitt Lymphoma, Childhood Chronic Myelogenous Leukemia, Childhood Diffuse Large Cell Lymphoma, Childhood Grade III Lymphomatoid Granulomatosis, Childhood Immunoblastic Large Cell Lymphoma, Childhood Myelodysplastic Syndromes, Childhood Nasal Type Extranodal NK/T-cell Lymphoma, Chronic Eosinophilic Leukemia, Chronic Myelomonocytic Leukemia, Chronic Neutrophilic Leukemia, Chronic Phase Chronic Myelogenous Leukemia, Cutaneous B-cell Non-Hodgkin Lymphoma, Essential Thrombocythemia, Extramedullary Plasmacytoma, Intraocular Lymphoma, Isolated Plasmacytoma of Bone, Juvenile Myelomonocytic Leukemia, Long-term Effects Secondary to Cancer Therapy in Children, Mast Cell Leukemia, Meningeal Chronic Myelogenous Leukemia, Monoclonal Gammopathy of Undetermined Significance, Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable, Polycythemia Vera, Post-transplant Lymphoproliferative Disorder, Primary Central Nervous System Hodgkin Lymphoma, Primary Central Nervous System Non-Hodgkin Lymphoma, Primary Myelofibrosis, Primary Systemic Amyloidosis, Progressive Hairy Cell Leukemia, Initial Treatment, Prolymphocytic Leukemia, Secondary Acute Myeloid Leukemia, Secondary Myelodysplastic Syndromes, Stage 0 Chronic Lymphocytic Leukemia, Stage I Childhood Anaplastic Large Cell Lymphoma, Stage I Childhood Hodgkin Lymphoma, Stage I Childhood Large Cell Lymphoma, Stage I Childhood Lymphoblastic Lymphoma, Stage I Childhood Small Noncleaved Cell Lymphoma, Stage I Chronic Lymphocytic Leukemia, Stage I Cutaneous T-cell Non-Hodgkin Lymphoma, Stage I Multiple Myeloma, Stage I Mycosis Fungoides/Sezary Syndrome, Stage II Childhood Anaplastic Large Cell Lymphoma, Stage II Childhood Hodgkin Lymphoma, Stage II Childhood Large Cell Lymphoma, Stage II Childhood Lymphoblastic Lymphoma, Stage II Childhood Small Noncleaved Cell Lymphoma, Stage II Chronic Lymphocytic Leukemia, Stage II Cutaneous T-cell Non-Hodgkin Lymphoma, Stage II Multiple Myeloma, Stage II Mycosis Fungoides/Sezary Syndrome, Stage III Childhood Anaplastic Large Cell Lymphoma, Stage III Childhood Hodgkin Lymphoma, Stage III Childhood Large Cell Lymphoma, Stage III Childhood Lymphoblastic Lymphoma, Stage III Childhood Small Noncleaved Cell Lymphoma, Stage III Chronic Lymphocytic Leukemia, Stage III Cutaneous T-cell Non-Hodgkin Lymphoma, Stage III Multiple Myeloma, Stage III Mycosis Fungoides/Sezary Syndrome, Stage IV Childhood Anaplastic Large Cell Lymphoma, Stage IV Childhood Hodgkin Lymphoma, Stage IV Childhood Large Cell Lymphoma, Stage IV Childhood Lymphoblastic Lymphoma, Stage IV Childhood Small Noncleaved Cell Lymphoma, Stage IV Chronic Lymphocytic Leukemia, Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma, Stage IV Mycosis Fungoides/Sezary Syndrome, T-cell Large Granular Lymphocyte Leukemia, Unspecified Childhood Solid Tumor, Protocol Specific, Untreated Childhood Acute Lymphoblastic Leukemia, Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies, Untreated Hairy Cell Leukemia, Waldenström Macroglobulinemia
    Bevacizumab in Treating Patients With Recurrent Sex Cord-Stromal Tumors of the Ovary
    University of Iowa Hospitals and Clinics
    Iowa City, Iowa 52242
    Ovarian Stromal Cancer
    A Placebo-Controlled Study of Saracatinib (AZD0530) in Patients With Recurrent Osteosarcoma Localized to the Lung
    University of Iowa Hospitals and Clinics
    Iowa City, Iowa 52242
    Osteosarcoma
    Efficacy and Safety Study of OncoVEXGM-CSF Compared to GM-CSF in Melanoma
    University of Iowa Hospitals & Clinics
    Iowa City, Iowa 52242
    Melanoma
    Neuropsychological and Behavioral Testing in Young Patients With Cancer
    University of Iowa Hospitals and Clinics
    Iowa City, Iowa 52242
    Chemotherapeutic Agent Toxicity, Cognitive/Functional Effects, Neurotoxicity, Psychosocial Effects of Cancer and Its Treatment, Radiation Toxicity, Unspecified Childhood Solid Tumor, Protocol Specific
    Paclitaxel, Paclitaxel Albumin-Stabilized Nanoparticle Formulation, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or Stage IV Breast Cancer
    University of Iowa Hospitals and Clinics
    Iowa City, Iowa 52242
    Male Breast Cancer, Recurrent Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast Cancer
    Filgrastim-Mobilized Stem Cells for Transplantation Using Unrelated Donors
    Iowa Marrow Donor Program
    Iowa City, Iowa 52242
    Healthy
    Paclitaxel and Cisplatin or Topotecan With or Without Bevacizumab in Treating Patients With Stage IVB, Recurrent, or Persistent Cervical Cancer
    University of Iowa Hospitals and Clinics
    Iowa City, Iowa 52242
    Cervical Adenocarcinoma, Cervical Adenosquamous Cell Carcinoma, Cervical Squamous Cell Carcinoma, Recurrent Cervical Cancer, Stage IVB Cervical Cancer
    Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II Endometrial Cancer
    Holden Comprehensive Cancer Center at University of Iowa
    Iowa City, Iowa 52242-1002
    Endometrial Cancer, Fatigue, Neurotoxicity
    A Study for Patients With Pancreatic Cancer
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Iowa City, Iowa
    Pancreatic Neoplasms
    177Lu Radiolabeled Monoclonal Antibody HuJ591 (177Lu-J591) and Ketoconazole in Patients With Prostate Cancer
    University of Iowa Hospitals and Clinics
    Iowa City, Iowa 52242
    Prostate Cancer
    Study of Immunotherapy to Treat Advanced Prostate Cancer
    University of Iowa Hospitals and Clinics
    Iowa City, Iowa 52242
    Prostate Cancer
    Paclitaxel With or Without Carboplatin and/or Bevacizumab Followed By Doxorubicin and Cyclophosphamide in Treating Patients With Breast Cancer That Can Be Removed by Surgery
    University of Iowa Hospitals and Clinics
    Iowa City, Iowa 52242
    Estrogen Receptor-negative Breast Cancer, HER2-negative Breast Cancer, Male Breast Cancer, Progesterone Receptor-negative Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Triple-negative Breast Cancer
    Evaluating the Safety and Effectiveness of an Umbilical Cord Blood Stem Cell Transplant That Uses Low Dose Chemotherapy in People With Leukemia or Lymphoma (BMT CTN #0604)
    University of Iowa Hospitals and Clinics
    Iowa City, Iowa 52242
    Precursor B-Cell Lymphoblastic Leukemia-Lymphoma, Leukemia, Myeloid, Acute, Burkitt Lymphoma, Lymphoma, B-Cell, Lymphoma, Follicular, Lymphoma, Large B-Cell, Diffuse
    Zoledronic Acid in Treating Patients With Metastatic Breast Cancer, Metastatic Prostate Cancer, or Multiple Myeloma With Bone Involvement
    Holden Comprehensive Cancer Center at University of Iowa

    Trial Locations
    Holden Comprehensive Cancer Center at University of Iowa
    Veterans Affairs Medical Center - Iowa City
    Breast Cancer, Metastatic Cancer, Multiple Myeloma and Plasma Cell Neoplasm, Musculoskeletal Complications, Pain, Prostate Cancer, Urinary Complications
    Anti-TF Antibody (ALT-836) to Treat Septic Patients With Acute Lung Injury or Acute Respiratory Distress Syndrome
    University of Iowa
    Iowa City, Iowa 52242
    Sepsis, Acute Lung Injury, Acute Respiratory Distress Syndrome
    Temozolomide and Radiation Therapy With or Without Bevacizumab in Treating Patients With Newly Diagnosed Glioblastoma
    University of Iowa Hospitals and Clinics
    Iowa City, Iowa 52242
    Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma
    Bevacizumab With or Without Everolimus in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
    University of Iowa Hospitals and Clinics
    Iowa City, Iowa 52242
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Brivanib Alaninate in Treating Patients With Recurrent or Persistent Endometrial Cancer
    Holden Comprehensive Cancer Center at University of Iowa
    Iowa City, Iowa 52242-1002
    Endometrial Cancer
    Collecting and Storing Samples of Bone Marrow and Blood From Patients With Relapsed Acute Lymphoblastic Leukemia or Non-Hodgkin Lymphoma
    Holden Comprehensive Cancer Center at University of Iowa
    Iowa City, Iowa 52242-1002
    Leukemia, Lymphoma
    Collecting Tumor Samples From Patients With Gynecological Tumors
    Holden Comprehensive Cancer Center at University of Iowa
    Iowa City, Iowa 52242-1002
    Cancer
    Imaging of Radiolabeled White Blood Cells in Patients With Non-Hodgkin's Lymphoma
    Holden Comprehensive Cancer Center at University of Iowa
    Iowa City, Iowa 52242-1002
    Lymphoma, Small Intestine Cancer
    Collecting and Storing Malignant, Borderline Malignant Neoplasms, and Related Samples From Young Patients With Cancer
    Holden Comprehensive Cancer Center at University of Iowa
    Iowa City, Iowa 52242-1002
    Leukemia, Neoplasm of Uncertain Malignant Potential, Unspecified Childhood Solid Tumor, Protocol Specific
    Study of Kidney Tumors in Young Patients
    Holden Comprehensive Cancer Center at University of Iowa
    Iowa City, Iowa 52242-1002
    Kidney Cancer, Nonneoplastic Condition
    Tumor Marker YKL-40 in Patients With Newly Diagnosed Stage III or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer Undergoing Chemotherapy
    Holden Comprehensive Cancer Center at University of Iowa
    Iowa City, Iowa 52242-1002
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Collecting and Storing Blood, Bone Marrow, and Other Samples From Patients With Acute Leukemia, Chronic Leukemia, or Myelodysplastic Syndromes
    Holden Comprehensive Cancer Center at University of Iowa

    Trial Locations
    Holden Comprehensive Cancer Center at University of Iowa
    Veterans Affairs Medical Center - Iowa City
    Leukemia, Lymphoma, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms
    Studying Tissue and Blood Samples From Patients With Acute Myeloid Leukemia
    Holden Comprehensive Cancer Center at University of Iowa
    Iowa City, Iowa 52242-1002
    Leukemia
    Collecting and Storing Biological Samples From Young Patients With Hodgkin's Lymphoma
    Holden Comprehensive Cancer Center at University of Iowa
    Iowa City, Iowa 52242-1002
    Lymphoma
    Study of Radiation Exposure and Bilateral Breast Cancer
    University of Iowa
    Iowa City, Iowa 52242
    Breast Cancer
    Biomarkers in Tumor Tissue Samples From Patients With Newly Diagnosed Neuroblastoma or Ganglioneuroblastoma
    Holden Comprehensive Cancer Center at University of Iowa
    Iowa City, Iowa 52242-1002
    Neuroblastoma
    Collecting and Storing Tissue, Blood, and Bone Marrow Samples From Patients With Rhabdomyosarcoma or Other Soft Tissue Sarcoma
    University of Iowa Hospitals and Clinics
    Iowa City, Iowa 52242
    Adult Rhabdomyosarcoma, Childhood Desmoplastic Small Round Cell Tumor, Chordoma, Desmoid Tumor, Metastatic Childhood Soft Tissue Sarcoma, Nonmetastatic Childhood Soft Tissue Sarcoma, Previously Treated Childhood Rhabdomyosarcoma, Previously Untreated Childhood Rhabdomyosarcoma, Recurrent Adult Soft Tissue Sarcoma, Recurrent Childhood Rhabdomyosarcoma, Recurrent Childhood Soft Tissue Sarcoma, Stage I Adult Soft Tissue Sarcoma, Stage II Adult Soft Tissue Sarcoma, Stage III Adult Soft Tissue Sarcoma, Stage IV Adult Soft Tissue Sarcoma